ACXP, NCM
Acurx Pharmaceuticals, Inc. (ACXP)
Price (as of October 24)
3.05USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
4D Molecular Therapeutics, Inc. |
-0.36 |
|
Armata Pharmaceuticals, Inc. |
-0.33 |
|
IVERIC bio, Inc. |
-0.32 |
|
Gelesis Holdings, Inc. |
-0.32 |
|
Anixa Biosciences, Inc. |
-0.31 |
|
Genenta Science S.p.A. |
-0.09 |
|
Genmab A/S |
-0.02 |
|
HilleVax, Inc. |
-0.17 |
|
Day One Biopharmaceuticals, Inc. |
0.04 |
|
PolyPid Ltd. |
-0.08 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Annovis Bio, Inc. |
0.41 |
|
Champions Oncology, Inc. |
0.4 |
|
Apellis Pharmaceuticals, Inc. |
0.35 |
|
Vigil Neuroscience, Inc. |
0.33 |
|
Applied Genetic Technologies Corporation |
0.32 |
|
Acer Therapeutics Inc. |
0.08 |
|
Assembly Biosciences, Inc. |
-0.07 |
|
Aravive, Inc. |
0.1 |
|
AVROBIO, Inc. |
0.07 |
|
Allogene Therapeutics, Inc. |
0.02 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Anixa Biosciences, Inc. |
-0.18 |
|
HilleVax, Inc. |
-0.17 |
|
IVERIC bio, Inc. |
-0.17 |
|
Arcturus Therapeutics Holdings Inc. |
-0.15 |
|
ALX Oncology Holdings Inc. |
-0.15 |
|
Alpine Immune Sciences, Inc. |
-0.12 |
|
NextCure, Inc. |
-0.13 |
|
Chemomab Therapeutics Ltd. |
-0.08 |
|
Ardelyx, Inc. |
0.01 |
|
AN2 Therapeutics, Inc. |
-0.14 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Achieve Life Sciences, Inc. |
0.24 |
|
Absci Corporation |
0.22 |
|
Achilles Therapeutics plc |
0.21 |
|
Adicet Bio, Inc. |
0.2 |
|
AC Immune SA |
0.2 |
|
Acasti Pharma Inc. |
0.13 |
|
ARCA biopharma, Inc. |
0.18 |
|
Aditxt, Inc. |
0.16 |
|
Entera Bio Ltd. |
0.16 |
|
Roivant Sciences Ltd. |
0.12 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
HilleVax, Inc. |
-0.17 |
|
Innate Pharma S.A. |
-0.16 |
|
Anixa Biosciences, Inc. |
-0.16 |
|
AN2 Therapeutics, Inc. |
-0.14 |
|
Rallybio Corporation |
-0.13 |
|
ALX Oncology Holdings Inc. |
-0.13 |
|
ZIVO Bioscience, Inc. |
-0.13 |
|
Wave Life Sciences Ltd. |
-0.13 |
|
NextCure, Inc. |
-0.13 |
|
GreenLight Biosciences Holdings |
-0.12 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Absci Corporation |
0.28 |
|
ARCA biopharma, Inc. |
0.18 |
|
Achilles Therapeutics plc |
0.17 |
|
Adicet Bio, Inc. |
0.17 |
|
Arcellx, Inc. |
0.17 |
|
Bionomics Limited |
0.17 |
|
AC Immune SA |
0.17 |
|
Aditxt, Inc. |
0.16 |
|
Entera Bio Ltd. |
0.16 |
|
Nutriband Inc. |
0.15 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
HilleVax, Inc. |
-0.17 |
|
Innate Pharma S.A. |
-0.16 |
|
Anixa Biosciences, Inc. |
-0.16 |
|
AN2 Therapeutics, Inc. |
-0.14 |
|
Rallybio Corporation |
-0.13 |
|
ALX Oncology Holdings Inc. |
-0.13 |
|
ZIVO Bioscience, Inc. |
-0.13 |
|
Wave Life Sciences Ltd. |
-0.13 |
|
NextCure, Inc. |
-0.13 |
|
GreenLight Biosciences Holdings |
-0.12 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Absci Corporation |
0.28 |
|
ARCA biopharma, Inc. |
0.18 |
|
Achilles Therapeutics plc |
0.17 |
|
Adicet Bio, Inc. |
0.17 |
|
Arcellx, Inc. |
0.17 |
|
Bionomics Limited |
0.17 |
|
AC Immune SA |
0.17 |
|
Aditxt, Inc. |
0.16 |
|
Entera Bio Ltd. |
0.16 |
|
Nutriband Inc. |
0.15 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
4D Molecular Therapeutics, Inc. |
-0.36 |
|
Armata Pharmaceuticals, Inc. |
-0.33 |
|
IVERIC bio, Inc. |
-0.32 |
|
Gelesis Holdings, Inc. |
-0.32 |
|
Anixa Biosciences, Inc. |
-0.31 |
|
Genenta Science S.p.A. |
-0.09 |
|
So-Young International Inc. |
-0.06 |
|
Doximity, Inc. |
0.04 |
|
TELA Bio, Inc. |
-0.02 |
|
Genmab A/S |
-0.02 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Annovis Bio, Inc. |
0.41 |
|
Champions Oncology, Inc. |
0.4 |
|
Apellis Pharmaceuticals, Inc. |
0.35 |
|
Vigil Neuroscience, Inc. |
0.33 |
|
Qiagen N.V. |
0.32 |
|
Apyx Medical Corporation |
-0.06 |
|
Applied Genetic Technologies Corporation |
0.13 |
|
agilon health, inc. |
0.11 |
|
Acer Therapeutics Inc. |
0.08 |
|
Assembly Biosciences, Inc. |
-0.07 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
R1 RCM Inc. |
-0.22 |
|
Anika Therapeutics, Inc. |
-0.21 |
|
Akerna Corp. |
-0.19 |
|
Amphastar Pharmaceuticals, Inc. |
-0.18 |
|
Anixa Biosciences, Inc. |
-0.18 |
|
Amedisys, Inc. |
-0.06 |
|
HilleVax, Inc. |
-0.17 |
|
IVERIC bio, Inc. |
-0.07 |
|
Meridian Bioscience, Inc. |
-0.17 |
|
American Well Corporation |
-0.11 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Achieve Life Sciences, Inc. |
0.24 |
|
Absci Corporation |
0.22 |
|
Inotiv, Inc. |
0.22 |
|
Achilles Therapeutics plc |
0.21 |
|
Akanda Corp. |
0.21 |
|
Adicet Bio, Inc. |
0.17 |
|
Agiliti, Inc. |
0.21 |
|
AC Immune SA |
0.17 |
|
Acasti Pharma Inc. |
0.13 |
|
ARCA biopharma, Inc. |
0.18 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
R1 RCM Inc. |
-0.22 |
|
Meridian Bioscience, Inc. |
-0.17 |
|
HilleVax, Inc. |
-0.17 |
|
Innate Pharma S.A. |
-0.16 |
|
Anixa Biosciences, Inc. |
-0.16 |
|
Akerna Corp. |
-0.14 |
|
Anika Therapeutics, Inc. |
-0.14 |
|
SOPHiA GENETICS SA |
-0.14 |
|
AN2 Therapeutics, Inc. |
-0.14 |
|
Rallybio Corporation |
-0.13 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Absci Corporation |
0.28 |
|
Akanda Corp. |
0.21 |
|
Agiliti, Inc. |
0.21 |
|
Inotiv, Inc. |
0.18 |
|
ARCA biopharma, Inc. |
0.18 |
|
Achilles Therapeutics plc |
0.17 |
|
Adicet Bio, Inc. |
0.17 |
|
Arcellx, Inc. |
0.17 |
|
Bionomics Limited |
0.17 |
|
AcelRx Pharmaceuticals, Inc. |
0.17 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
R1 RCM Inc. |
-0.22 |
|
Meridian Bioscience, Inc. |
-0.17 |
|
HilleVax, Inc. |
-0.17 |
|
Innate Pharma S.A. |
-0.16 |
|
Anixa Biosciences, Inc. |
-0.16 |
|
Akerna Corp. |
-0.14 |
|
Anika Therapeutics, Inc. |
-0.14 |
|
SOPHiA GENETICS SA |
-0.14 |
|
AN2 Therapeutics, Inc. |
-0.14 |
|
Rallybio Corporation |
-0.13 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Absci Corporation |
0.28 |
|
Akanda Corp. |
0.21 |
|
Agiliti, Inc. |
0.21 |
|
Inotiv, Inc. |
0.18 |
|
ARCA biopharma, Inc. |
0.18 |
|
Achilles Therapeutics plc |
0.17 |
|
Adicet Bio, Inc. |
0.17 |
|
Arcellx, Inc. |
0.17 |
|
Bionomics Limited |
0.17 |
|
AcelRx Pharmaceuticals, Inc. |
0.17 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Great Southern Bancorp, Inc. |
-0.46 |
|
HeartCore Enterprises, Inc. |
-0.45 |
|
Triumph Bancorp, Inc. |
-0.44 |
|
Barclays Bank PLC |
-0.4 |
|
Janus Henderson Group plc |
-0.39 |
|
PowerShares DB Crude Oil Double Short ETN |
-0.1 |
|
India Internet & Ecommerce ETF |
-0.19 |
|
DHC Acquisition Corp. |
-0.04 |
|
Amplify Pure Junior Gold Miners ETF |
-0.04 |
|
ING Groep N.V. |
-0.05 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Bridgewater Bancshares, Inc. |
0.5 |
|
Aberdeen Global Dynamic Dividend Fund |
0.45 |
|
Albertsons Companies, Inc. |
0.43 |
|
Antelope Enterprise Holdings Limited |
0.42 |
|
Annovis Bio, Inc. |
0.41 |
|
Champions Oncology, Inc. |
0.05 |
|
Aehr Test Systems |
0.09 |
|
The Bank of Nova Scotia |
0.03 |
|
Albemarle Corporation |
0.25 |
|
CyberArk Software Ltd. |
-0.01 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
JPMorgan International Research Enhanced Equity ETF |
-0.27 |
|
ManTech International Corporation |
-0.26 |
|
Nubia Brand International Corp. |
-0.24 |
|
HeartCore Enterprises, Inc. |
-0.23 |
|
Velocity Acquisition Corp. |
-0.22 |
|
R1 RCM Inc. |
-0.22 |
|
Anika Therapeutics, Inc. |
-0.14 |
|
Biglari Holdings Inc. |
-0.2 |
|
Swvl Holdings Corp. |
-0.21 |
|
Patria Latin American Opportunity Acquisition Corp. |
-0.21 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Actelis Networks, Inc. |
0.32 |
|
Aberdeen Global Dynamic Dividend Fund |
0.3 |
|
Albemarle Corporation |
0.29 |
|
Antelope Enterprise Holdings Limited |
0.29 |
|
Ashford Hospitality Trust, Inc. |
0.28 |
|
Aberdeen Emerging Markets Equity Income Fund Inc |
0.25 |
|
First Majestic Silver Corp. |
0.24 |
|
ALPS Clean Energy ETF |
0.2 |
|
Express, Inc. |
0.21 |
|
BondBloxx B-Rated USD High Yield Corporate Bond ETF |
0.25 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
JPMorgan International Research Enhanced Equity ETF |
-0.27 |
|
Nubia Brand International Corp. |
-0.24 |
|
HeartCore Enterprises, Inc. |
-0.23 |
|
R1 RCM Inc. |
-0.22 |
|
Swvl Holdings Corp. |
-0.21 |
|
Patria Latin American Opportunity Acquisition Corp. |
-0.21 |
|
First Merchants Corporation |
-0.21 |
|
Biglari Holdings Inc. |
-0.2 |
|
iShares Blockchain and Tech ETF |
-0.2 |
|
Goldman Sachs Access Emerging Markets USD Bond ETF |
-0.2 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Actelis Networks, Inc. |
0.32 |
|
Zymergen Inc. |
0.29 |
|
Absci Corporation |
0.28 |
|
Worksport Ltd. |
0.27 |
|
Albemarle Corporation |
0.25 |
|
Aberdeen Emerging Markets Equity Income Fund Inc |
0.25 |
|
BondBloxx B-Rated USD High Yield Corporate Bond ETF |
0.25 |
|
Ashford Hospitality Trust, Inc. |
0.24 |
|
First Majestic Silver Corp. |
0.24 |
|
AltEnergy Acquisition Corp. |
0.23 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
JPMorgan International Research Enhanced Equity ETF |
-0.27 |
|
Nubia Brand International Corp. |
-0.24 |
|
HeartCore Enterprises, Inc. |
-0.23 |
|
R1 RCM Inc. |
-0.22 |
|
Swvl Holdings Corp. |
-0.21 |
|
Patria Latin American Opportunity Acquisition Corp. |
-0.21 |
|
First Merchants Corporation |
-0.21 |
|
Biglari Holdings Inc. |
-0.2 |
|
iShares Blockchain and Tech ETF |
-0.2 |
|
Goldman Sachs Access Emerging Markets USD Bond ETF |
-0.2 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Actelis Networks, Inc. |
0.32 |
|
Zymergen Inc. |
0.29 |
|
Absci Corporation |
0.28 |
|
Worksport Ltd. |
0.27 |
|
Albemarle Corporation |
0.25 |
|
Aberdeen Emerging Markets Equity Income Fund Inc |
0.25 |
|
BondBloxx B-Rated USD High Yield Corporate Bond ETF |
0.25 |
|
Ashford Hospitality Trust, Inc. |
0.24 |
|
First Majestic Silver Corp. |
0.24 |
|
AltEnergy Acquisition Corp. |
0.23 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York.